2/14/2018China Reviews Achievements of the BMI System and Medical Assistance Pr...

2/13/2018MOLOGEN Signs Deal with ONCOLOGIE for Lead Compound Lefitolimod

2/13/2018GNC Announces $300M Partnership with Harbin Pharma

2/13/2018GC Pharma and Lee's Pharm Enter into China Licensing Agreement for An...

2/13/2018MSD Files NDA for Anticancer Keytruda in China

2/13/2018CFDA Seeks Comments on Draft Document for Matters Related to Import Dr...

2/13/2018BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients ...

2/13/2018Chi-Med Enrolls 527 Patients in Pivotal Phase III FALUCA Trial of Fruq...

2/12/2018The Chinese Pharmaceutical Industry: Winners and Losers 2017

2/12/2018CFDA Publishes Its 2018 Legislation Plan

2/9/2018CFDA Issues Guidelines for Clinical Trials of HepB and Cerebral Ischem...

2/8/2018Recent Executive Moves

2/8/2018China's Medicine and Health Product Foreign Trade Rebounded in 2017

2/8/2018CDE Release Essential Dossier Data Requirements for PD-1/PD-L1 mAb Dru...

2/8/2018Chinese Researchers Finds New Potential Asthma Treatment

2/7/2018Review of Chinese Pharma Deals, R&D and Regulatory Developments in...

2/6/2018TaiGen's New IV Antibiotic Nemonoxacin Gets Fast Track Designation in ...

2/6/2018Xbrane Biopharma Licenses GnRH Analog Spherotide to CR Pharma in China

2/6/2018Pfizer, DL Medicine Enter Drug Discovery Partnership

2/6/2018South Korea's Pharmaceutical Export to China Jumped Nearly 400% in 201...

2/5/2018Shanghai AIC Penalizes U.S.-China Joint Venture for Providing Overseas...

2/5/2018More Provincial Governments Liberalize Non-essential Drug Use in Prima...

2/2/2018Shanghai AIC Terminates Antimonopoly Investigation of the City's GPO S...

2/2/2018Puma Biotech and CANbridge Enter Exclusive Licensing for NERLYNX (nera...

2/2/2018Shanghai Pharma Completes Acquisition of Cardinal Health's China Busin...

2/2/2018Recent Executive Moves

1/31/2018BeiGene Initiates Global Phase 3 Trial of Anti-PD-1 Antibody Tislelizu...

1/31/2018Financial-related Company News in Brief

1/31/2018Novartis Launches Asthma Drug Xolair (omalizumab) in China

1/30/2018Why Most Small Players May Not Survive China's Pharmaceutical Industry...

Page:145/334 Total number of articles:10001: [First][<<] [143] [144] [145] [146] [147] [>>] [End]